Nearly half of crypto pundits in a recent survey are bullish over crypto AI tokens prices — which could bode well for the $23.6 billion crypto market sector. 

Of the 2,632 respondents surveyed by CoinGecko between February and March, 25% were “fully bullish,” and 19.3% indicated they were “somewhat bullish” for crypto AI tokens in 2025.

Around 29% of respondents were neutral on the subject, while a combined 26.3% were either somewhat bearish or bearish. 

Responses on crypto AI product sentiment. Source: CoinGecko

The survey response was similar when it came to crypto AI products, which comes as the “use cases combining crypto with AI have improved and are seeing more widespread adoption,” said CoinGecko’s crypto research analyst Yuqian Lim.

“This perhaps shows that crypto participants are not differentiating between crypto AI’s investing or trading potential and the technology itself,” said Lim. 

“Such market sentiments might in turn reflect expectations that now is the time for crypto AI to move beyond the conceptual stage and mature as a sector.”

CoinGecko’s cryptocurrency tracker shows that the top artificial intelligence coins by market capitalization are around $23.6 billion, led by Near Protocol (NEAR), Internet Computer (ICP) and Bittensor (TAO). 

There’s also a separate group of AI agent coins, such as Artificial Super Intelligence (FET), Virtuals Protocol (VIRTUAL), ai16z (AI16z) and others, which command a market cap of $4.5 billion. 

CoinGecko surveyed 2,632 participants between Feb. 20 and March 10 and grouped participants whether they were long-term crypto investors or short-term traders. 

It also asked participants to categorize themselves on whether they saw themselves as early or late adopters and laggards of crypto AI.

It found that some of the earliest adopters — known as “innovators” — had a higher share of bearishness compared to some of the later adopters. “Laggards” were the most bearish, in line with expectations. 

Responses on crypto AI product sentiment between the innovator, early adopter, early majority, late majority and laggard groups. Source: CoinGecko

Related: 83% of institutions plan to up crypto allocations in 2025: Coinbase

Spencer Farrar, a partner at the AI and crypto-focused venture capital firm Theory Ventures, recently told Cointelegraph that these AI applications are “a bit frothy” at the moment, but more utility could come down the line.

Farrar expects to see further experimentation with crypto AI tokens, as they allow retail investors to speculate on smaller market cap ideas that largely aren’t as accessible in the stock market.

“Things tend to start off like this in the open-source world; you see a ton of tinkering, and then perhaps we’ll see something really big come of it.”

Crypto AI verticals that Farrar’s firm has a close eye on include decentralized GPU provider protocols, decentralized data providers, payment infrastructure for AI agents leveraging blockchain tech and crypto trading bots.“There’s also an opportunity for crypto to be used as a video to authenticate content as AI-generated or human-generated,” Farrar added.

Magazine: Memecoins are ded — But Solana ‘100x better’ despite revenue plunge

NASDAQ-listed biopharmaceutical firm Atai Life Sciences says cryptocurrencies like Bitcoin could be key to survival for biotech startups as they wade through years of regulatory approvals. 

Atai, which is developing mental health treatments using psychedelics like DMT and MDMA, has become the latest public company to announce plans to buy Bitcoin.

It plans to buy $5 million of Bitcoin (BTC), its founder and chair Christian Angermayer wrote in a March 20 Substack post.

“Drug development is a cash-hungry, long-term venture,” he said. “The necessary steps to achieve regulatory approval can easily take more than a decade.”

TechCrunch reported in January that, according to multiple data sets, the number of startups shutting down rose in 2024 compared to 2023 as firms failed to receive more funding to keep running.

Angermayer said the approval process is essential for drug development, but it exposes firms to financial risks while sticky inflation and high interest rates have caused the current “biotech winter.”

Source: Christian Angermayer

He added that the current industry approach is to put cash reserves in near-zero-yield accounts, as “preserving capital was more important than earning a return on their cash balance.”

“This context sets the stage for considering unconventional treasury moves — like adding Bitcoin to the treasury — to address the twin threats of inflation and low-yielding reserves, and in general to optimize and maximize shareholder value.”

Atai will join at least five other public medical companies that have bought Bitcoin in recent months with the aim of boosting shareholder returns.

Biotech firm Quantum BioPharma said on March 20 that it had now spent $3.5 million in total to buy BTC and other cryptocurrencies after an initial $1 million investment in December. 

Medical device maker Semler Scientific said last month that since it started in May, it had spent a total of $280.4 million buying 3,192 BTC.

Hoth Therapeutics, Acurx Pharmaceuticals and Enlivex Therapeutics said in separate statements on Nov. 20 that each of them would buy $1 million in Bitcoin.

Related: Michael Saylor’s Strategy plans to offer 5M shares to buy more Bitcoin

Atai’s Angermayer said his firm’s Bitcoin buy would primarily be as a long-term inflation hedge but also a short-term diversification play. He added that Bitcoin is likely to have short-term price fluctuations, so the Berlin-based firm is holding mostly US dollars, short-term securities, and stocks for its desired run rate into 2027.

Atai’s $5 million put would mean it is able to buy just over 59 BTC at its current price of around $84,300 and make it the world’s 52nd largest holder among public firms, according to Bitbo data.

Bitcoin has struggled to keep afloat amid a wider market rout due to US President Donald Trump’s tariff threats and fears of a US recession, which Trump hasn’t ruled out.

Atai’s share price rose early in March 20 trading to a peak of $1.47 but tapered off to close the day down 1.44% at $1.37, according to Google Finance. Its stock has sunk nearly 93% from its mid-2021 public debut peak but is up 3% so far this year.

Magazine: Crypto fans are obsessed with longevity and biohacking — Here’s why

NASDAQ-listed biopharmaceutical firm Atai Life Sciences says cryptocurrencies like Bitcoin could be key to survival for biotech startups as they wade through years of regulatory approvals. 

Atai, which is developing mental health treatments using psychedelics like DMT and MDMA, has become the latest public company to announce plans to buy Bitcoin.

It plans to buy $5 million of Bitcoin (BTC), its founder and chair Christian Angermayer wrote in a March 20 Substack post.

“Drug development is a cash-hungry, long-term venture,” he said. “The necessary steps to achieve regulatory approval can easily take more than a decade.”

TechCrunch reported in January that, according to multiple data sets, the number of startups shutting down rose in 2024 compared to 2023 as firms failed to receive more funding to keep running.

Angermayer said the approval process is essential for drug development, but it exposes firms to financial risks while sticky inflation and high interest rates have caused the current “biotech winter.”

Source: Christian Angermayer

He added that the current industry approach is to put cash reserves in near-zero-yield accounts, as “preserving capital was more important than earning a return on their cash balance.”

“This context sets the stage for considering unconventional treasury moves — like adding Bitcoin to the treasury — to address the twin threats of inflation and low-yielding reserves, and in general to optimize and maximize shareholder value.”

Atai will join at least five other public medical companies that have bought Bitcoin in recent months with the aim of boosting shareholder returns.

Biotech firm Quantum BioPharma said on March 20 that it had now spent $3.5 million in total to buy BTC and other cryptocurrencies after an initial $1 million investment in December. 

Medical device maker Semler Scientific said last month that since it started in May, it had spent a total of $280.4 million buying 3,192 BTC.

Hoth Therapeutics, Acurx Pharmaceuticals and Enlivex Therapeutics said in separate statements on Nov. 20 that each of them would buy $1 million in Bitcoin.

Related: Michael Saylor’s Strategy plans to offer 5M shares to buy more Bitcoin

Atai’s Angermayer said his firm’s Bitcoin buy would primarily be as a long-term inflation hedge but also a short-term diversification play. He added that Bitcoin is likely to have short-term price fluctuations, so the Berlin-based firm is holding mostly US dollars, short-term securities, and stocks for its desired run rate into 2027.

Atai’s $5 million put would mean it is able to buy just over 59 BTC at its current price of around $84,300 and make it the world’s 52nd largest holder among public firms, according to Bitbo data.

Bitcoin has struggled to keep afloat amid a wider market rout due to US President Donald Trump’s tariff threats and fears of a US recession, which Trump hasn’t ruled out.

Atai’s share price rose early in March 20 trading to a peak of $1.47 but tapered off to close the day down 1.44% at $1.37, according to Google Finance. Its stock has sunk nearly 93% from its mid-2021 public debut peak but is up 3% so far this year.

Magazine: Crypto fans are obsessed with longevity and biohacking — Here’s why

NASDAQ-listed biopharmaceutical firm Atai Life Sciences says cryptocurrencies like Bitcoin could be key to survival for biotech startups as they wade through years of regulatory approvals. 

Atai, which is developing mental health treatments using psychedelics like DMT and MDMA, has become the latest public company to announce plans to buy Bitcoin.

It plans to buy $5 million of Bitcoin (BTC), its founder and chair Christian Angermayer wrote in a March 20 Substack post.

“Drug development is a cash-hungry, long-term venture,” he said. “The necessary steps to achieve regulatory approval can easily take more than a decade.”

TechCrunch reported in January that, according to multiple data sets, the number of startups shutting down rose in 2024 compared to 2023 as firms failed to receive more funding to keep running.

Angermayer said the approval process is essential for drug development, but it exposes firms to financial risks while sticky inflation and high interest rates have caused the current “biotech winter.”

Source: Christian Angermayer

He added that the current industry approach is to put cash reserves in near-zero-yield accounts, as “preserving capital was more important than earning a return on their cash balance.”

“This context sets the stage for considering unconventional treasury moves — like adding Bitcoin to the treasury — to address the twin threats of inflation and low-yielding reserves, and in general to optimize and maximize shareholder value.”

Atai will join at least five other public medical companies that have bought Bitcoin in recent months with the aim of boosting shareholder returns.

Biotech firm Quantum BioPharma said on March 20 that it had now spent $3.5 million in total to buy BTC and other cryptocurrencies after an initial $1 million investment in December. 

Medical device maker Semler Scientific said last month that since it started in May, it had spent a total of $280.4 million buying 3,192 BTC.

Hoth Therapeutics, Acurx Pharmaceuticals and Enlivex Therapeutics said in separate statements on Nov. 20 that each of them would buy $1 million in Bitcoin.

Related: Michael Saylor’s Strategy plans to offer 5M shares to buy more Bitcoin

Atai’s Angermayer said his firm’s Bitcoin buy would primarily be as a long-term inflation hedge but also a short-term diversification play. He added that Bitcoin is likely to have short-term price fluctuations, so the Berlin-based firm is holding mostly US dollars, short-term securities, and stocks for its desired run rate into 2027.

Atai’s $5 million put would mean it is able to buy just over 59 BTC at its current price of around $84,300 and make it the world’s 52nd largest holder among public firms, according to Bitbo data.

Bitcoin has struggled to keep afloat amid a wider market rout due to US President Donald Trump’s tariff threats and fears of a US recession, which Trump hasn’t ruled out.

Atai’s share price rose early in March 20 trading to a peak of $1.47 but tapered off to close the day down 1.44% at $1.37, according to Google Finance. Its stock has sunk nearly 93% from its mid-2021 public debut peak but is up 3% so far this year.

Magazine: Crypto fans are obsessed with longevity and biohacking — Here’s why

The serial entrepreneur who founded the Mt. Gox crypto exchange and co-founded Ripple has shared new details about his ambitious space station company Vast, which he hopes will help expand the human race into a multi-planetary species.

In a March 20 interview with Bloomberg, Jed McCaleb confirmed that Vast is on track to launch Haven-1 — a commercial space station still under construction — into orbit by May 2026.

If McCaleb’s startup succeeds, it will be better positioned to win a lucrative contract from the US National Aeronautics and Space Administration to replace the International Space Station. Contracts are expected to be handed out in mid-2026.

If Vast fails or loses the NASA contract to a competitor, McCaleb could see $1 billion wiped from his net worth and the commercial future of his space station firm would be in doubt, according to the report. 

“There are not that many folks who are willing to dedicate the amount of resources and time and risk tolerance that I am,” McCaleb told Bloomberg.

Vast’s founder, board chair and tech fellow Jed McCaleb. Source: Vast

McCaleb is known to be a “deliberate risk-taker” with hyperrational tendencies, according to long-time friend and former business partner Sam Yagan, who added:

“He’s maybe slightly eccentric in his willingness to take what you and I would see as a lot of risks.”

McCaleb’s aspiration to put humans on other planets draws similarities to multibillionaire and SpaceX CEO Elon Musk.

“It’s super important that people take this leap from where we are today to this potential world where there’s a lot of people living off the Earth,” said McCaleb, who founded Vast in 2021.

Vast is building its spacecraft with components developed by SpaceX, such as a docking adapter to connect SpaceX’s Dragon capsule to Vast’s station and an in-space internet system that will provide WiFi on the station via Starlink.

Key specifications Vast’s Haven-1 model. Source: Vast

McCaleb’s firm has also booked SpaceX flights to send its hardware into orbit and deliver crew to its station, and SpaceX has agreed to carry astronauts for Vast as long as NASA gives its go-ahead.

Vast’s close ties to SpaceX stem partly from it hiring key personnel who previously worked there, including Max Haot, who now serves as Vast’s CEO and president.

Vast is competing with the likes of Axiom Space, Voyager Space Holdings, Lockheed Martin and the Jeff Bezos-founded Blue Origin to win the next major NASA contract.

McCaleb also wants to create “artificial gravity”

Part of Vast’s long-term plans is to create artificial gravity replicating Earth-like conditions by accelerating or rotating the spacecraft, as many ISS workers who have spent lengthy periods in space have reported organ damage.

The ISS also uses a technology that recycles wastewater into potable water and carbon dioxide into breathable oxygen. Haven-1 won’t feature this due to its short-term crew visits, but Vast plans to incorporate it into its future model, Haven-2, by 2028, which will be designed for longer-term stays.

Both McCaleb and Haot say they’re willing to board flights themselves.

Related: SETI, NASA scientists think AI could teach aliens about Earth

McCaleb has followed an unconventional pathway into the space industry.

After McCaleb’s first success with the internet file-sharing service eDonkey in the 2000s, his next notable achievement was founding Mt. Gox in 2010.

His time at Mt. Gox was short-lived, with McCaleb selling a majority stake in 2011. Mt. Gox went on to become the world’s largest Bitcoin (BTC) exchange until 2014 when a $400 million hack sent the company into bankruptcy.

Several months later, McCaleb began his next venture — creating the XRP (XRP) crypto token on the Ripple protocol in 2012.

McCaleb owned 9% of the XRP tokens from the onset but sold the majority of them after 2013 when he left Ripple following disagreements with the company’s other founders.

He has netted billions of dollars from those XRP sales and Ripple equity between 2014 and 2022.

McCaleb also founded the Stellar network in 2014 — a fork of the Ripple protocol — along with the Stellar (XLM) crypto token, which now boasts an $8.7 billion market cap, CoinGecko data shows.

Magazine: Big Questions: Did the NSA create Bitcoin?

The serial entrepreneur who founded the Mt. Gox crypto exchange and co-founded Ripple has shared new details about his ambitious space station company Vast, which he hopes will help expand the human race into a multi-planetary species.

In a March 20 interview with Bloomberg, Jed McCaleb confirmed that Vast is on track to launch Haven-1 — a commercial space station still under construction — into orbit by May 2026.

If McCaleb’s startup succeeds, it will be better positioned to win a lucrative contract from the US National Aeronautics and Space Administration to replace the International Space Station. Contracts are expected to be handed out in mid-2026.

If Vast fails or loses the NASA contract to a competitor, McCaleb could see $1 billion wiped from his net worth and the commercial future of his space station firm would be in doubt, according to the report. 

“There are not that many folks who are willing to dedicate the amount of resources and time and risk tolerance that I am,” McCaleb told Bloomberg.

Vast’s founder, board chair and tech fellow Jed McCaleb. Source: Vast

McCaleb is known to be a “deliberate risk-taker” with hyperrational tendencies, according to long-time friend and former business partner Sam Yagan, who added:

“He’s maybe slightly eccentric in his willingness to take what you and I would see as a lot of risks.”

McCaleb’s aspiration to put humans on other planets draws similarities to multibillionaire and SpaceX CEO Elon Musk.

“It’s super important that people take this leap from where we are today to this potential world where there’s a lot of people living off the Earth,” said McCaleb, who founded Vast in 2021.

Vast is building its spacecraft with components developed by SpaceX, such as a docking adapter to connect SpaceX’s Dragon capsule to Vast’s station and an in-space internet system that will provide WiFi on the station via Starlink.

Key specifications Vast’s Haven-1 model. Source: Vast

McCaleb’s firm has also booked SpaceX flights to send its hardware into orbit and deliver crew to its station, and SpaceX has agreed to carry astronauts for Vast as long as NASA gives its go-ahead.

Vast’s close ties to SpaceX stem partly from it hiring key personnel who previously worked there, including Max Haot, who now serves as Vast’s CEO and president.

Vast is competing with the likes of Axiom Space, Voyager Space Holdings, Lockheed Martin and the Jeff Bezos-founded Blue Origin to win the next major NASA contract.

McCaleb also wants to create ‘artificial gravity’

Part of Vast’s long-term plans is to create artificial gravity replicating Earth-like conditions by accelerating or rotating the spacecraft, as many ISS workers who have spent lengthy periods in space have reported organ damage.

The ISS also uses a technology that recycles wastewater into potable water and carbon dioxide into breathable oxygen. Haven-1 won’t feature this due to its short-term crew visits, but Vast plans to incorporate it into its future model, Haven-2, by 2028, which will be designed for longer-term stays.

Both McCaleb and Haot say they’re willing to board flights themselves.

Related: SETI, NASA scientists think AI could teach aliens about Earth

McCaleb has followed an unconventional pathway into the space industry.

After McCaleb’s first success with the internet file-sharing service eDonkey in the 2000s, his next notable achievement was founding Mt. Gox in 2010.

His time at Mt. Gox was short-lived, with McCaleb selling a majority stake in 2011. Mt. Gox went on to become the world’s largest Bitcoin (BTC) exchange until 2014 when a $400 million hack sent the company into bankruptcy.

Several months later, McCaleb began his next venture — creating the XRP (XRP) crypto token on the Ripple protocol in 2012.

McCaleb owned 9% of the XRP tokens from the onset but sold the majority of them after 2013 when he left Ripple following disagreements with the company’s other founders.

He has netted billions of dollars from those XRP sales and Ripple equity between 2014 and 2022.

McCaleb also founded the Stellar network in 2014 — a fork of the Ripple protocol — along with the Stellar (XLM) crypto token, which now boasts an $8.7 billion market cap, CoinGecko data shows.

Magazine: Big Questions: Did the NSA create Bitcoin?

The serial entrepreneur who founded the Mt. Gox crypto exchange and co-founded Ripple has shared new details about his ambitious space station company Vast, which he hopes will help expand the human race into a multi-planetary species.

In a March 20 interview with Bloomberg, Jed McCaleb confirmed that Vast is on track to launch Haven-1 — a commercial space station still under construction — into orbit by May 2026.

If McCaleb’s startup succeeds, it will be better positioned to win a lucrative contract from the US National Aeronautics and Space Administration to replace the International Space Station. Contracts are expected to be handed out in mid-2026.

If Vast fails or loses the NASA contract to a competitor, McCaleb could see $1 billion wiped from his net worth and the commercial future of his space station firm would be in doubt, according to the report. 

“There are not that many folks who are willing to dedicate the amount of resources and time and risk tolerance that I am,” McCaleb told Bloomberg.

Vast’s founder, board chair and tech fellow Jed McCaleb. Source: Vast

McCaleb is known to be a “deliberate risk-taker” with hyperrational tendencies, according to long-time friend and former business partner Sam Yagan, who added:

“He’s maybe slightly eccentric in his willingness to take what you and I would see as a lot of risks.”

McCaleb’s aspiration to put humans on other planets draws similarities to multibillionaire and SpaceX CEO Elon Musk.

“It’s super important that people take this leap from where we are today to this potential world where there’s a lot of people living off the Earth,” said McCaleb, who founded Vast in 2021.

Vast is building its spacecraft with components developed by SpaceX, such as a docking adapter to connect SpaceX’s Dragon capsule to Vast’s station and an in-space internet system that will provide WiFi on the station via Starlink.

Key specifications Vast’s Haven-1 model. Source: Vast

McCaleb’s firm has also booked SpaceX flights to send its hardware into orbit and deliver crew to its station, and SpaceX has agreed to carry astronauts for Vast as long as NASA gives its go-ahead.

Vast’s close ties to SpaceX stem partly from it hiring key personnel who previously worked there, including Max Haot, who now serves as Vast’s CEO and president.

Vast is competing with the likes of Axiom Space, Voyager Space Holdings, Lockheed Martin and the Jeff Bezos-founded Blue Origin to win the next major NASA contract.

McCaleb also wants to create ‘artificial gravity’

Part of Vast’s long-term plans is to create artificial gravity replicating Earth-like conditions by accelerating or rotating the spacecraft, as many ISS workers who have spent lengthy periods in space have reported organ damage.

The ISS also uses a technology that recycles wastewater into potable water and carbon dioxide into breathable oxygen. Haven-1 won’t feature this due to its short-term crew visits, but Vast plans to incorporate it into its future model, Haven-2, by 2028, which will be designed for longer-term stays.

Both McCaleb and Haot say they’re willing to board flights themselves.

Related: SETI, NASA scientists think AI could teach aliens about Earth

McCaleb has followed an unconventional pathway into the space industry.

After McCaleb’s first success with the internet file-sharing service eDonkey in the 2000s, his next notable achievement was founding Mt. Gox in 2010.

His time at Mt. Gox was short-lived, with McCaleb selling a majority stake in 2011. Mt. Gox went on to become the world’s largest Bitcoin (BTC) exchange until 2014 when a $400 million hack sent the company into bankruptcy.

Several months later, McCaleb began his next venture — creating the XRP (XRP) crypto token on the Ripple protocol in 2012.

McCaleb owned 9% of the XRP tokens from the onset but sold the majority of them after 2013 when he left Ripple following disagreements with the company’s other founders.

He has netted billions of dollars from those XRP sales and Ripple equity between 2014 and 2022.

McCaleb also founded the Stellar network in 2014 — a fork of the Ripple protocol — along with the Stellar (XLM) crypto token, which now boasts an $8.7 billion market cap, CoinGecko data shows.

Magazine: Big Questions: Did the NSA create Bitcoin?

Bitcoin-stacking firm Metaplanet has appointed US President Donald Trump’s son, Eric Trump, to its newly established Strategic Board of Advisors to further Metaplanet’s mission to become a “global leader in the Bitcoin economy.””His business acumen, love of the Bitcoin community and global hospitality perspective will be invaluable in accelerating Metaplanet’s vision of becoming one of the world’s leading Bitcoin Treasury Companies,” Metaplanet’s CEO Simon Gerovich said in a March 21 announcement on X.”As a globally recognized business leader and entrepreneur, Eric Trump brings a wealth of experience in real estate, finance, brand development, and strategic business growth and has become a leading voice and advocate of digital asset adoption worldwide,” Metaplanet added.

*Metaplanet Appoints Eric Trump to Strategic Board of Advisors* pic.twitter.com/v3CaFgLJkW

— Metaplanet Inc. (@Metaplanet_JP) March 21, 2025

The move is part of Metaplanet’s plan to establish a Board of influential voices, speakers and thought leaders around the world who are committed to furthering Bitcoin adoption.Metaplanet currently holds 3,050 Bitcoin (BTC) worth nearly $4.1 billion, BitBo’s BitcoinTreasuries.NET data shows.

Metaplanet is thrilled to welcome Eric Trump to our newly formed Strategic Board of Advisors. His business expertise and passion for BTC will help drive our mission forward as we continue building one of the world’s leading Bitcoin Treasury Companies.Welcome aboard @EricTrump! pic.twitter.com/c0bpC1ojcg

— Simon Gerovich (@gerovich) March 21, 2025

This is a developing story, and further information will be added as it becomes available.

Bitcoin-stacking firm Metaplanet has appointed US President Donald Trump’s son Eric to its newly established strategic board of advisers to further Metaplanet’s mission to become a “global leader in the Bitcoin economy.””His business acumen, love of the Bitcoin community and global hospitality perspective will be invaluable in accelerating Metaplanet’s vision of becoming one of the world’s leading Bitcoin Treasury Companies,” Metaplanet CEO Simon Gerovich said in a March 21 announcement on X.”As a globally recognized business leader and entrepreneur, Eric Trump brings a wealth of experience in real estate, finance, brand development, and strategic business growth and has become a leading voice and advocate of digital asset adoption worldwide,” Metaplanet added.

Metaplanet’s March 21 letter appointing Eric Trump to the firm’s Strategic Board of Advisors. Source: Metaplanet

The move is part of Metaplanet’s plan to establish a board of influential voices, speakers and thought leaders around the world who are committed to furthering Bitcoin adoption.Metaplanet shares increased 17.8% to 4,730 Japanese yen ($31.74) over the first 80 minutes of the March 21 trading day on the Tokyo Stock Exchange, Google Finance data shows.

Source: Simon Gerovich

Metaplanet currently holds 3,050 Bitcoin (BTC) — worth nearly $4.1 billion — making it the 12th largest corporate Bitcoin holder, BitBo’s BitcoinTreasuries.NET data shows.The Japan-based investment firm set a target to accumulate at least 10,000 Bitcoin before the end of 2025. Gerovich’s firm has purchased 1,288 Bitcoin over the first 11 or so weeks of 2025 — a substantial rise in pace compared to 2024 but not quite on track to reach the ambitious target.Related: Bitcoin price thaws after Trump statement — Trader says ‘stay nimble and cashed up’

The company has been adopting a range of financial instruments to bolster its Bitcoin reserve since it made its first purchase on April 23, 2024.Meanwhile, Eric Trump has been a key contributor to the Trump family’s World Liberty Financial crypto platform, which completed its second token sale in March 2025, bringing its total funding to $550 million.The Trump-affiliated platform currently holds $80.8 million worth of crypto assets, according to crypto analytics platform Arkham Intelligence.The president’s son also recently revealed that his personal crypto holdings include Bitcoin, Ether (ETH), Solana (SOL) and Sui (SUI).

Magazine: Trump’s crypto ventures raise conflict of interest, insider trading questions

Bitcoin-stacking firm Metaplanet has appointed US President Donald Trump’s son Eric to its newly established strategic board of advisers to further Metaplanet’s mission to become a “global leader in the Bitcoin economy.””His business acumen, love of the Bitcoin community and global hospitality perspective will be invaluable in accelerating Metaplanet’s vision of becoming one of the world’s leading Bitcoin Treasury Companies,” Metaplanet CEO Simon Gerovich said in a March 21 announcement on X.”As a globally recognized business leader and entrepreneur, Eric Trump brings a wealth of experience in real estate, finance, brand development, and strategic business growth and has become a leading voice and advocate of digital asset adoption worldwide,” Metaplanet added.

*Metaplanet Appoints Eric Trump to Strategic Board of Advisors* pic.twitter.com/v3CaFgLJkW

— Metaplanet Inc. (@Metaplanet_JP) March 21, 2025

The move is part of Metaplanet’s plan to establish a board of influential voices, speakers and thought leaders around the world who are committed to furthering Bitcoin adoption.Related: Bitcoin price thaws after Trump statement — Trader says ‘stay nimble and cashed up’Metaplanet shares increased 17.8% to 4,730 Japanese yen ($31.74) over the first 80 minutes of the March 21 trading day on the Tokyo Stock Exchange, Google Finance data shows.Metaplanet currently holds 3,050 Bitcoin (BTC) — worth nearly $4.1 billion — making it the 12th largest corporate Bitcoin holder, BitBo’s BitcoinTreasuries.NET data shows.The Japan-based firm has been adopting a range of financial instruments to bolster its Bitcoin reserve since it made its first purchase on April 23, 2024.Magazine: Trump’s crypto ventures raise conflict of interest, insider trading questions

Metaplanet is thrilled to welcome Eric Trump to our newly formed Strategic Board of Advisors. His business expertise and passion for BTC will help drive our mission forward as we continue building one of the world’s leading Bitcoin Treasury Companies.Welcome aboard @EricTrump! pic.twitter.com/c0bpC1ojcg

— Simon Gerovich (@gerovich) March 21, 2025

This is a developing story, and further information will be added as it becomes available.